CRISPR News Medicine publishes an article entitled Adaptation of jumping gene boosts CRISPR-Cas gene-writing technology to new heights about new FiCAT platform developed by Integra Therapeutics.
By Henri van de Vrugt
CRISPR News Medicine publishes an article entitled Adaptation of jumping gene boosts CRISPR-Cas gene-writing technology to new heights about new FiCAT platform developed by Integra Therapeutics.
By Henri van de Vrugt
Integra Therapeutics S.L. uses its own and third-party cookies to analyse the use of the website and to show you advertising related to your preferences based on a profile drawn up from your browsing habits (for example, pages visited). Cookie Policy here.